Hoth Therapeutics Valuation
| HOTH Stock | USD 1.04 0.02 1.89% |
Today, the firm appears to be overvalued. Hoth Therapeutics retains a regular Real Value of $1.0 per share. The prevalent price of the firm is $1.04. Our model calculates the value of Hoth Therapeutics from evaluating the firm fundamentals such as Return On Equity of -0.83, shares owned by insiders of 0.93 %, and Return On Asset of -0.46 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Hoth Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Hoth Therapeutics is based on 3 months time horizon. Increasing Hoth Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hoth Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hoth Stock. However, Hoth Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.04 | Real 1.0 | Hype 1.04 | Naive 0.84 |
The intrinsic value of Hoth Therapeutics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Hoth Therapeutics' stock price.
Estimating the potential upside or downside of Hoth Therapeutics helps investors to forecast how Hoth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hoth Therapeutics more accurately as focusing exclusively on Hoth Therapeutics' fundamentals will not take into account other important factors: Hoth Therapeutics Total Value Analysis
Hoth Therapeutics is currently anticipated to have valuation of 7.53 M with market capitalization of 15.51 M, debt of 55.16 K, and cash on hands of 11.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Hoth Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.53 M | 15.51 M | 55.16 K | 11.62 M |
Hoth Therapeutics Asset Utilization
One of the ways to look at asset utilization of Hoth is to check how much profit was generated for every dollar of assets it reports. Hoth Therapeutics retains a negative application of resources of -0.46 (percent), losing $0.004616 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Hoth Therapeutics shows how discouraging it operates for each dollar spent on its resources.Hoth Therapeutics Ownership Allocation
The market capitalization of Hoth Therapeutics is $15.51 Million. Roughly 95.55 (percent) of Hoth Therapeutics outstanding shares are held by general public with 0.93 % owned by insiders and only 3.53 pct. by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Hoth Therapeutics Profitability Analysis
Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0.About Hoth Therapeutics Valuation
An absolute valuation paradigm, as applied to Hoth Stock, attempts to find the value of Hoth Therapeutics based on its fundamental and basic technical indicators. By analyzing Hoth Therapeutics's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Hoth Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hoth Therapeutics. We calculate exposure to Hoth Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hoth Therapeutics's related companies.Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Hoth Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3.4 M |
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |